ALC
Alcon AGNYSEHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$37.30B
P/E Ratio
37.69
EPS
$1.98
Beta
0.74
52W High
$98.85
52W Low
$71.55
50-Day MA
$79.39
200-Day MA
$80.27
Dividend Yield
0.45%
Profit Margin
9.42%
Forward P/E
21.88
PEG Ratio
1.71
About Alcon AG
Alcon, Inc., an eye care company, researches, develops, manufactures, distributes and sells eye care products for eye care professionals and their patients around the world. The company is headquartered in Geneva, Switzerland.
Fundamentals
| Revenue (TTM) | $10.40B |
| Gross Profit (TTM) | $5.79B |
| EBITDA | $2.33B |
| Operating Margin | 11.70% |
| Return on Equity | 4.50% |
| Return on Assets | 2.57% |
| Revenue/Share (TTM) | $21.09 |
| Book Value | $45.20 |
| Price-to-Book | 1.65 |
| Price-to-Sales (TTM) | 3.59 |
| EV/Revenue | 3.929 |
| EV/EBITDA | 15.14 |
| Quarterly Earnings Growth (YoY) | -22.20% |
| Quarterly Revenue Growth (YoY) | 8.60% |
| Shares Outstanding | $487.43M |
| Float | $486.27M |
| % Insiders | 0.18% |
| % Institutions | 67.79% |
Analyst Ratings
Consensus ($95.31 target)
4
Strong Buy17
Buy7
Hold1
Strong SellData last updated: 4/7/2026